Published :
Tables : 67
Figures : 45
Category : Healthcare
No. of Pages : 218
Report Code : HC-U3182
Biomarkers Market is poised to value over USD 77.2 billion by 2027 end at a CAGR of over 13.5% during the forecast period 2020 to 2027 Growing usage of biomarkers in diagnostic applications, increased research and development funding for biotech and pharma companies, low costs of clinical trials in developing and underdeveloped countries and rapid prevalence of cancer across the world are some key driving factors that contribute in the growth of the market. FutureWise Market Research has instantiated a report that provides an intricate analysis of Biomarkers Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Biomarkers Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Biomarkers Market: PERKINELMER INC. MERCK MILLIPORE BIO-RAD LABORATORIES ENZO BIOCHEM INC. EKF DIAGNOSTICS HOLDINGS INC. MESO SCALE DIAGNOSTICS LLC. BIOSIMS TECHNOLOGIES SAS CISBIO BIOASSAYS SIGNOSIS INC. (Note: The list of the major players will be updated with the latest market scenario and trends) Biomarkers Market Segmentation: By Product Consumables Services Software By Type Safety Biomarkers Efficacy Biomarkers Predictive Biomarkers Surrogate Biomarkers Pharmacodynamic Biomarkers Prognostic Biomarkers Validation Biomarkers By Application Diagnostics Drug Discovery and Development Personalized Medicine Disease Risk Assessment Other Applications By Disease Indication Cancer Cardiovascular Disorders Neurological Disorders Immunological Disorders Other Diseases By Region North America Europe Asia-Pacific Rest of the world Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the Biomarkers Market By Product, By Type, By Application, By Disease Indication and By Region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Growing usage of biomarkers in diagnostic applications, increased research and development funding for biotech and pharma companies, low costs of clinical trials in developing and underdeveloped countries and rapid prevalence of cancer across the world are some key driving factors that contribute in the growth of the market. FutureWise Market Research has instantiated a report that provides an intricate analysis of Biomarkers Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Biomarkers Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Biomarkers Market:
(Note: The list of the major players will be updated with the latest market scenario and trends)
Biomarkers Market Segmentation:
By Product
By Type
By Application
By Disease Indication
By Region
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Biomarkers Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Application Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Disease Indication Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Biomarkers Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Application Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Biomarkers Market Analysis Tools 6.1. Application Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Disease Indication Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Disease Indication Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Biomarkers Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Consumables 7.2. Services 7.3. Software 8. Global Biomarkers Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Safety Biomarkers 8.2. Efficacy Biomarkers 8.2.1. Predictive Biomarkers 8.2.2. Surrogate Biomarkers 8.2.3. Pharmacodynamic Biomarkers 8.2.4. Prognostic Biomarkers 8.3. Validation Biomarkers 9. Global Biomarkers Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Diagnostics 9.2. Drug Discovery and Development 9.3. Personalized Medicine 9.4. Disease Risk Assessment 9.5. Other Applications 10. Global Biomarkers Market, By Disease Indication Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Cancer 10.2. Cardiovascular Disorders 10.3. Neurological Disorders 10.4. Immunological Disorders 10.5. Other Diseases 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Regional Market Trends 12.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.3.1. Brazil 12.3.2. Venezuela 12.3.3. Argentina 12.3.4. Rest of Latin America 12.4. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Switzerland 13.2.9. Rest of Western Europe 13.3. Market Size (USD Million) Forecast for Europe 2020-2027 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. Singapore 14.2.4. India 14.2.5. Australia and New Zealand 14.2.6. ASEAN 14.2.7. South Korea 14.2.8. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 16.1. PERKINELMER INC. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. MERCK MILLIPORE 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. BIO-RAD LABORATORIES 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. ENZO BIOCHEM INC. 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 EKF DIAGNOSTICS HOLDINGS INC. 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 MESO SCALE DIAGNOSTICS LLC. 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. BIOSIMS TECHNOLOGIES SAS 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. CISBIO BIOASSAYS 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. SIGNOSIS INC. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 17. FutureWise SME Key Takeaway Points for Client
1. Market Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.3.2 Market Covered
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3. Executive Summary
3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Global Biomarkers Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Application Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Disease Indication Overview
4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview
5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Biomarkers Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Application Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Biomarkers Market Analysis Tools 6.1. Application Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Disease Indication Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Disease Indication Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Biomarkers Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
7.1. Consumables
7.2. Services
7.3. Software
8. Global Biomarkers Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Safety Biomarkers
8.2. Efficacy Biomarkers
8.2.1. Predictive Biomarkers
8.2.2. Surrogate Biomarkers
8.2.3. Pharmacodynamic Biomarkers
8.2.4. Prognostic Biomarkers
8.3. Validation Biomarkers
9. Global Biomarkers Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
9.1. Diagnostics
9.2. Drug Discovery and Development
9.3. Personalized Medicine
9.4. Disease Risk Assessment
9.5. Other Applications
10. Global Biomarkers Market, By Disease Indication Historical Analysis and Forecast 2020-2027 (USD Million)
10.1. Cancer
10.2. Cardiovascular Disorders
10.3. Neurological Disorders
10.4. Immunological Disorders
10.5. Other Diseases
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.2.1. U.S.A
11.2.2. Canada
11.2.3. Mexico
11.3. Market Size (USD Million) Forecast for North America 2020-2027
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Regional Market Trends
12.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.3.1. Brazil
12.3.2. Venezuela
12.3.3. Argentina
12.3.4. Rest of Latin America
12.4. Market Size (USD Million) Forecast for Latin America 2020-2027
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Germany
13.2.2. U.K
13.2.3. France
13.2.4. Italy
13.2.5. Spain
13.2.6. Russia
13.2.7. Poland
13.2.8. Switzerland
13.2.9. Rest of Western Europe
13.3. Market Size (USD Million) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
14.1. Introduction
14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
14.2.1. Japan
14.2.2. China
14.2.3. Singapore
14.2.4. India
14.2.5. Australia and New Zealand
14.2.6. ASEAN
14.2.7. South Korea
14.2.8. Rest of Asia Pacific
14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
15.1. Introduction
15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
15.2.1. Saudi Arabia
15.2.2. UAE
15.2.3. South Africa
15.2.4. Egypt
15.3. Market Size (USD Million) Forecast for MEA 2020-2027
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
16.1. PERKINELMER INC.
16.1.1. Company Overview
16.1.2. Product Portfolio
16.1.3. SWOT Analysis
16.1.4. Financial Overview
16.1.5. Strategic Overview
16.2. MERCK MILLIPORE
16.2.1. Company Overview
16.2.2. Product Portfolio
16.2.3. SWOT Analysis
16.2.4. Financial Overview
16.2.5. Strategic Overview
16.3. BIO-RAD LABORATORIES
16.3.1. Company Overview
16.3.2. Product Portfolio
16.3.3. SWOT Analysis
16.3.4. Financial Overview
16.3.5. Strategic Overview
16.4. ENZO BIOCHEM INC.
16.4.1. Company Overview
16.4.2. Product Portfolio
16.4.3. SWOT Analysis
16.4.4. Financial Overview
16.4.5. Strategic Overview
16.5 EKF DIAGNOSTICS HOLDINGS INC.
16.5.1. Company Overview
16.5.2. Product Portfolio
16.5.3. SWOT Analysis
16.5.4. Financial Overview
16.5.5. Strategic Overview
16.6 MESO SCALE DIAGNOSTICS LLC.
16.6.1. Company Overview
16.6.2. Product Portfolio
16.6.3. SWOT Analysis
16.6.4. Financial Overview
16.6.5. Strategic Overview
16.7. BIOSIMS TECHNOLOGIES SAS
16.7.1. Company Overview
16.7.2. Product Portfolio
16.7.3. SWOT Analysis
16.7.4. Financial Overview
16.7.5. Strategic Overview
16.8. CISBIO BIOASSAYS
16.8.1. Company Overview
16.8.2. Product Portfolio
16.8.3. SWOT Analysis
16.8.4. Financial Overview
16.8.5. Strategic Overview
16.9. SIGNOSIS INC.
16.9.1. Company Overview
16.9.2. Product Portfolio
16.9.3. SWOT Analysis
16.9.4. Financial Overview
16.9.5. Strategic Overview
17. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics